Grand Brilliance Group publishes 2026 annual report

PUBT · 2d ago
Grand Brilliance Group publishes 2026 annual report
  • Grand Brilliance published its annual report for the year ended March 31, 2026, citing stable Hong Kong conditions despite a tougher global backdrop.
  • Business expansion centered on a broader product portfolio, stronger R&D capability, improved customer service, and a push toward one-stop medical device solutions.
  • Set up a new subsidiary to support development of an in-house medical device brand, positioning the group for longer-term growth.
  • Revenue growth was driven by tender wins tied to hospital expansion under Hong Kong’s First Hospital Development Plan.
  • Declared an interim dividend of HK0.25 cent per share in lieu of a final dividend, payable Aug. 10, 2026 to holders on record July 17, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grand Brilliance Group Holdings Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260721-12251326), on July 21, 2026, and is solely responsible for the information contained therein.